America November 14, 2025
Day One to Acquire Mersana Therapeutics in High-Stakes $285M Cancer Drug Deal
In a dramatic move that reshapes the biopharma landscape, Day One Biopharmaceuticals revealed Thursday that it will acquire Mersana Therapeutics…
America November 14, 2025
In a dramatic move that reshapes the biopharma landscape, Day One Biopharmaceuticals revealed Thursday that it will acquire Mersana Therapeutics…
By Rihem Akkouche
America September 27, 2025
A Massachusetts-based biotech says two pharmaceutical giants are trampling its intellectual property. Factor Bioscience Inc. filed suit Friday in Delaware…
By Rihem Akkouche
America November 30, 2023
In a stunning pre-market announcement, AbbVie Inc. has declared its intention to acquire ImmunoGen Inc., a prominent player in cancer…
By Rochdi Rais